Trial intelligence / Profile preview

Boostrix in pregnant women

2014-001119-38Phase 4Completed

Sponsor
GSK
Start
Mar 2015
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, single-blind trial in pertussis, diphtheria and Tetanus comparing Boostrix during pregnancy with Placebo during pregnancy (2 arms). Primary endpoint: Primary immunogenicity endpoint. Started Mar 2015; status: completed.

02

Drugs

acellular pertussis vaccine
03

Conditions

pertussisdiphtheriaTetanus

Beyond the preview

Go deeper on 2014-001119-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-001119-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call